Search research articles
Contact Us
Filters
Showing results (11-20 of 65) with videos related to
Page
of 7
Sort By:
Zhonghua Yi Xue Za Zhi
|
March 21, 2020
[Ten hot issues on diagnosis and treatment of breast cancer under the outbreak of novel coronavirus pneumonia]
Z F Jiang, J B Li
Zhonghua Yi Xue Za Zhi
|
November 3, 2025
[Key points in the Chinese experts' consensus on the diagnosis and treatment of HER2-targeted breast cancer 2025 edition]
J B Li, Z F Jiang
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]
|
February 20, 2020
[Development of guidelines and clinical practice for breast cancer]
Z F Jiang, J B Li
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]
|
December 30, 2020
[Opportunity and challenge of neoadjuvant treatment in triple negative breast cancer]
X P Hao, Z F Jiang
Zhonghua Yi Xue Za Zhi
|
October 8, 2021
[Chinese Society of Clinical Oncology Breast Cancer Guideline version 2021: updates and interpretations]
J B Li, Z F Jiang
Zhonghua Yi Xue Za Zhi
|
February 7, 2017
[Expert Forums Treatment decisions in precision medicine: the big data and small random]
F R Xu, Z F Jiang
Zhonghua Yi Xue Za Zhi
|
August 15, 2020
[Key points of diagnosis and treatment for HER2 positive breast cancer]
F R Xu, Z F Jiang
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]
|
January 26, 2022
[Cold thinking on ten hot issues in the treatment of early breast cancer]
J B Li, Z F Jiang
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
December 22, 2016
[Research progress of circulating tumor cells: the way from counting to subtyping]
J B Li, Z F Jiang
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]
|
February 7, 2017
[Calm thinking for precision medicine of breast cancer in the boom]
Z F Jiang, F R Xu
Page
of 7
Search research articles
Search
Showing results (11-20 of 65) with videos related to
Sort By:
Page
of 7
Zhonghua Yi Xue Za Zhi
|
March 21, 2020
[Ten hot issues on diagnosis and treatment of breast cancer under the outbreak of novel coronavirus pneumonia]
Z F Jiang, J B Li
Zhonghua Yi Xue Za Zhi
|
November 3, 2025
[Key points in the Chinese experts' consensus on the diagnosis and treatment of HER2-targeted breast cancer 2025 edition]
J B Li, Z F Jiang
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]
|
February 20, 2020
[Development of guidelines and clinical practice for breast cancer]
Z F Jiang, J B Li
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]
|
December 30, 2020
[Opportunity and challenge of neoadjuvant treatment in triple negative breast cancer]
X P Hao, Z F Jiang
Zhonghua Yi Xue Za Zhi
|
October 8, 2021
[Chinese Society of Clinical Oncology Breast Cancer Guideline version 2021: updates and interpretations]
J B Li, Z F Jiang
Zhonghua Yi Xue Za Zhi
|
February 7, 2017
[Expert Forums Treatment decisions in precision medicine: the big data and small random]
F R Xu, Z F Jiang
Zhonghua Yi Xue Za Zhi
|
August 15, 2020
[Key points of diagnosis and treatment for HER2 positive breast cancer]
F R Xu, Z F Jiang
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]
|
January 26, 2022
[Cold thinking on ten hot issues in the treatment of early breast cancer]
J B Li, Z F Jiang
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
December 22, 2016
[Research progress of circulating tumor cells: the way from counting to subtyping]
J B Li, Z F Jiang
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]
|
February 7, 2017
[Calm thinking for precision medicine of breast cancer in the boom]
Z F Jiang, F R Xu
Page
of 7